What does sumsummit therapeutics do? Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridioides difficile infection (CDI).What is summit therapeutics doing to expand its pipeline? We are currently developing new mechanism antibiotics for C. difficile infection and are using our proprietary Discuva Platform to expand our pipeline. Today Summit Therapeutics is displaying three preeminent ePosters at the prestigious 31st European Congress of Clinical Microbiology & Infectious Diseases.What is summit therapeutics incs iss governance quality score? The company was founded in 2003 and is based in Cambridge, Massachusetts. Summit Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A. Corporate governance scores courtesy of Institutional Shareholder Services (ISS).What is sumsummits partnership with carb x? Summit is proud to partner with CARB-X, as announced on May 18, 2021, to progress the development of its precision antibiotic candidate, SMT-738, through its IND-enabling and Phase Ia clinical trials for the treatment of highly-resistant CRE bacterial infections.
Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF WARRANTS Oxford, UK, 23 February 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development
SMMT Summit Therapeutics Inc Small Company Offering and Sale of Securities Without Registration (d) o NoneEntity Type0001599298Summit Therapeutics plcSummit Corp plc x Corporation o Limited Partnership o Limited Liability Company o General Partnership o Business Trust o OtherName
Director Deals - Summit Therapeutics PLC (SUMM) Robert Duggan, Non Executive Director, sold 33,321,870 shares in the company ...
Summit Therapeutics Limited is an active company incorporated on 4 August 2004 with the registered office located in Abingdon, Oxfordshire. Summit Therapeutics Limited has been running for 16 years. There are currently 2 active directors according to the latest confirmation statement submitted on 19th September 2020.